Wisconsin Alumni Research Foundation

Potent New Drug for Type 2 Diabetes, Obesity – 2023 WARF Innovation Award Nominee

With the commercial success of two well-known brands, pharmaceutical companies have an intense interest in additional therapeutics for the treatment of both obesity and type 2 diabetes. Ralph F. Hirschmann Prof. Samuel Gellman worked with postdoc Kyle Brown and graduate student Rylie Morris to develop a synthetic peptide that uses a more simplified design to target the same mechanisms of the drugs currently on the market.

To disclose your invention visit:

To license a WARF technology visit:

Other Videos